Companies that pay high dividend yields are great, but it’s also important to consider whether those dividends are sustainable.

Two of the companies I’m looking at today are infrastructure or infrastructure-like companies, typified by long contracts that provide income certainty.

That gives investors some certainty that the business, if managed well, can make long-term forecasts for its income and liabilities and, hopefully, keep its dividend payments steady.

Let’s look at the companies I’ve selected that currently pay solid dividends.

Aurizon Ltd (ASX: AZJ)

Rail operator Aurizon is currently paying a 6.18% dividend yield, 90% franked.

The company’s shares are also up about 18% over the past year, despite a recent dip after the announcement of its results.

After releasing its results, Aurizon announced a new $250 million share buyback, following a buyback completed during FY26.

The company grew EBITDA last financial year by 9% to $1.72 billion, and paid out 90% of its net profit as dividends.

Aurizon is expecting to pay 23 cents to 24 cents per share in dividends this year, which would be a 6.4% dividend yield at the current share price.

Atlas Arteria Ltd (ASX: ALX)

This toll road operator faced a takeover bid during the year, which contributed to the company posting a net loss. However, apart from that, the company described its performance as stable.

Brokers expect Atlas to maintain its distribution at 40 cents per share, in line with current-year guidance, which yields 8.7%.

The company itself said it will no longer provide guidance for dividend payments beyond a one year period.

The company added:

Going forward, we will continue to focus on optimising free cash flow to drive strong distributions. Distributions will align with free cash flow by maintaining the distribution policy to pay 90–110% of free cash flow on a full-year basis.

Regal Partners Ltd (ASX: RPL)

Financial services company Regal Partners is currently paying a very healthy dividend yield of 11.1%, after more than doubling its net profit over the past financial year.

The company’s Managing Director Brendan O’Connor said their balance sheet was “exceptionally strong”, with $290 million in capital on hand after the payment of the dividend, along with excess franking credits.

Mr O’Connor said at the time:

I also note the investment landscape continues to evolve rapidly, shaped by an artificial intelligence fuelled capital expenditure boom, shifting geopolitical dynamics, the proposed removal of the capital gains tax discount regime, and persistent inflation. Against this backdrop, we are seeing growing demand for income-oriented products and look forward to launching our Multi-Strategy Income Fund in September. More broadly, we believe our suite of alternative strategies is very well placed to meet client needs in this environment.

The post 3 ASX shares with dividend yields of between 6% and 11% appeared first on The Motley Fool Australia.

More reading

• How much superannuation do I need to earn $80,000 per year in passive income?
• How much passive income can I earn off a $750,000 superannuation balance?
• How much passive income could a $500,000 superannuation balance generate?
• How much is needed in superannuation for $3,000 in weekly passive income?
• $10,000 a year in passive income buying just $10k worth of ASX shares? Here’s how I’d go about it

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

After a period of seemingly relentless declines, CSL Ltd (ASX: CSL) shares have finally found some love in recent weeks.

In fact, the biotech giant’s shares have been on an absolute tear, rising almost 90% since hitting a multi-year low of $90.00 in June.

Those gains are not too surprising given the dirt cheap valuation at the time, but what about the future? 

Do analysts think CSL shares are going higher or lower from here? Let’s dig deeper into things and find out.

Where next for CSL shares?

Before looking at where the company’s shares could be heading, let’s have a quick reminder of why they have rallied.

As I mentioned at the top, the CSL share price was well and truly down in the doldrums at just $90.00.

This was a level that investors hadn’t seen in over a decade. Not even during the COVID market crash did its shares get anywhere near that level.

The market was essentially valuing CSL like it was broken and without a fix. 

However, a much better than expected FY 2026 result and improving confidence in its outlook helped change the narrative and investors came flooding back.

Which is why CSL shares are suddenly trading at $169.50 today.

Though, it is worth noting that this is still well short of its record high, so we are only in the early stages of a full recovery.

What are brokers predicting?

The good news is that a number of top brokers still see value in the company’s shares despite its strong gains over the past three months.

For example, the team at UBS has a buy rating and $181.00 price target on them. This implies potential upside of around 7% over the next 12 months.

Elsewhere, Morgan Stanley has an overweight rating and slightly higher price target of $182.00.

And over at Morgans, its analysts have a buy rating and $187.71 price target, which offers potential upside of approximately 11%. It said:

The FY26 result was broadly in line with expectations, with revenue of US$15.8bn (+3% vs guidance) and underlying NPATA of US$3.1bn. Importantly, underlying Ig demand remains strong, Seqirus delivered seasonal influenza growth despite lower US immunisation rates and transformation savings reached US$176m ahead of target, although Vifor continues to face challenges. 

While FY27 targets flat top line growth, as Vifor remains a significant drag, the earnings trajectory is becoming increasingly skewed towards recovery, supported by stabilising plasma economics, cost-outs and improved commercial execution. We make modest changes to FY27-28 estimates and increase our blended DCF, PE and EV/EBITDA-based target price to A$187.71 on a multiple roll forward. BUY.

It is worth noting that not everyone is positive. Macquarie has a neutral rating and $133.00 price target and Bell Potter is sitting at hold with a $150.00 price target.

The post Higher or lower: Where are CSL shares going next? appeared first on The Motley Fool Australia.

More reading

• ASX healthcare shares are 39% higher since June. Are you missing out?
• CSL shares are up 90%. Brokers can’t agree what happens next
• 2 ASX shares I think could return more than Westpac
• How much superannuation do I need to earn $100 a day in passive income?
• CSL shares are up 90%. How much higher can they go?

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Macquarie Group. The Motley Fool Australia has recommended CSL and Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Looking to bank an extra $5,000 of passive income in FY 2027 from Qantas Airways Ltd (ASX: QAN) shares?

With shares in the S&P/ASX 200 Index (ASX: XJO) airline having returned to earth following their record highs in August last year, now could be an opportune entry point to get a market beating yield from those Qantas dividends.

As you may recall, it was only back in April 2025 that Qantas’ twice yearly dividend payouts resumed. The airline suspended its passive income payments in 2020 amid the travel crushing impacts of the global pandemic.

But with air travel having resumed, and profits rolling in, the Qantas dividend is back in play.

Tapping into the ASX 200 airline for dividends

Over the past 12 months, Qantas has declared two fully franked dividends, both 19.8 cents per share.

Qantas paid the interim dividend on 15 April.

The final Qantas dividend will be paid out on 14 October.

That passive income payout is still up for grabs, by the way. Qantas shares trade ex-dividend on 15 September. So, you’ll need to own stock in the Flying Kangaroo at market close on Monday, 14 September, to claim that payout.

This also means that the yield we’re looking at here is partly a trailing yield and partly a pending yield.

Since we know how much the upcoming dividend is and the current Qantas share price, we can calculate the pending yield with certainty.

What we don’t know is the amount of the upcoming interim dividend next year. So, we’ll base that on this year’s interim payout.

Trailing yields, are by their nature, backwards looking. Future Qantas dividend payouts could be higher or lower depending on a range of macroeconomic and company specific factors. For Qantas that includes things like upcoming travel demand, and the trajectory of jet fuel costs, which analysts can only do their best to guess at today.

With that said…

How many Qantas shares do I need to buy for $5,000 in passive income?

Over the past 12 months, Qantas has paid – or shortly will pay – 39.6 cents per share in fully franked dividends.

At the recent share price of $9.05, the ASX 200 airline trades on a fully franked dividend yield (partly trailing, partly pending) of 4.4%.

So, to earn $5,000 of passive income in the 2027 financial year, you’d need to invest $113,636 in the stock today.

Or 12,557 Qantas shares.

The post How many Qantas shares do I need to buy for $5,000 of passive income in FY27? appeared first on The Motley Fool Australia.

More reading

• 33 ASX shares going ex-dividend next week
• Top 3 ASX 200 shares now below their 200-day moving average
• 3 ASX 200 shares tipped to return 27% to 87%
• Morgan Stanley tips Qantas shares to climb 38%
• 6 ASX shares tipped by brokers to rise 34% to 88%

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.